# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001021771-24-000027
Filing Date
2024-02-05
Accepted
2024-02-05 08:00:18
Documents
17
Period of Report
2024-02-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | RE AUTOLOGOUS STEM CELL THERAPY POSTER | brt8k2524.htm iXBRL | 8-K | 28543
2 | PRESS RELEASE | ex99_1.htm | EX-99.1 | 11956
3 | POSTER | ex99_2.htm | EX-99.2 | 518
7 |  | poster.jpg | GRAPHIC | 1367700
| Complete submission text file | 0001021771-24-000027.txt |  | 2060866

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | brtx-20240205.xsd | EX-101.SCH | 3884
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | brtx-20240205_lab.xml | EX-101.LAB | 22547
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | brtx-20240205_pre.xml | EX-101.PRE | 16057
18 | EXTRACTED XBRL INSTANCE DOCUMENT | brt8k2524_htm.xml | XML | 4058

Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 911835664 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 24593988
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)